- This event has passed.
February Research Ethics Consortium
February 17, 2017 @ 12:30 pm - 2:00 pm
Ethical Considerations in Pragmatic Cluster Randomized Trials
Reducing health care-associated infection is imperative, but approaches vary. In this pragmatic, comparative-effectiveness, cluster-randomized trial (CRT), multiple hospitals were randomly assigned to three different strategies to assess which was most effective in reducing ICU-attributable MRSA-positive clinical cultures.
Discussion will include issues Research Ethics Committees and Investigators contend with when reviewing and conducting CRTs and implementation research. How should regulatory and ethical informed consent requirements be handled? Does obtaining informed consent produce biased research? How does variability in review affect multi-site CRTs?
Elizabeth Hohmann, MD Associate Professor of Medicine, Harvard Medical School
Chair and Physician Director, Partners Human Research Committees
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital
Richard Platt, MD, MSc Professor and Chair of the Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute
Spencer Hey, PhD Research Fellow in Medicine, Harvard Medical School
Brigham and Women’s Hospital
Christine Mitchell, RN, MS, MTS Executive Director, Harvard Medical School Center for Bioethics